Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Jianshui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3283-0792; OpenAlex author ID A5036806179. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Co-author DOI 10.3389/fonc.2025.1521616↗
  2. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer. Co-author DOI 10.3389/fimmu.2024.1341209↗
  3. Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer via the Wnt/β-catenin pathway Last author DOI 10.21203/rs.3.rs-1976828/v1↗
  4. Comprehensive analysis of prognostic value and immune infiltration of calpains in pancreatic cancer. Co-author DOI 10.21037/jgo-21-705↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chuan Lan · 4 shared papers, 2021–2025 · strength 0.70
  2. Guangnian Zhang · 3 shared papers, 2022–2025 · strength 0.55
  3. Dawei Deng · 3 shared papers, 2022–2025 · strength 0.55
  4. Jun Qing Yu · 2 shared papers, 2024–2025 · strength 0.42
  5. Yong Li · 2 shared papers, 2024–2025 · strength 0.42
  6. Yifu Hou · 2 shared papers, 2021–2024 · strength 0.34
  7. Yi Chen · 1 shared paper, 2025 · strength 0.22
  8. Dongmei Ren · 1 shared paper, 2024 · strength 0.20
  9. Xiaobin Huang · 1 shared paper, 2022 · strength 0.13
  10. Jun Yu · 1 shared paper, 2022 · strength 0.13
  11. Xingyu Liu · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.